UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients ( TROPHIES ): Final patient‐reported outcomes at 24 months

Diabetes, obesity & metabolism, 2023-12, Vol.25 (12), p.3453-3464

2023

Volltextzugriff (PDF)

The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes ( TROPHIES ): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes

Diabetes, obesity & metabolism, 2023-12, Vol.25 (12), p.3465-3477

2023

Volltextzugriff (PDF)

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study

BMC geriatrics, 2018-02, Vol.18 (1), p.57-57, Article 57

2018

Volltextzugriff (PDF)

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes

Dementia and geriatric cognitive disorders extra, 2017-01, Vol.7 (1), p.87-100

2017

Volltextzugriff (PDF)

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data

Diabetes therapy, 2019-06, Vol.10 (3), p.1067-1088

2019

Volltextzugriff (PDF)

738-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Patient-Reported Outcomes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

746-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Primary Endpoint Analysis

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

726-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Clinical Characteristics and Treatment Pattern Analyses

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

672-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Twelve-Month Data Analysis

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan

Value in health regional issues, 2019-05, Vol.18, p.84-90

2019

Volltextzugriff (PDF)

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study

Diabetes therapy, 2018-04, Vol.9 (2), p.789-801

2018

Volltextzugriff (PDF)

Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis

Diabetes therapy, 2021-05, Vol.12 (5), p.1553-1567

2021

Volltextzugriff (PDF)

Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c

Journal of diabetes and its complications, 2020-07, Vol.34 (7), p.107575-107575, Article 107575

2020

Volltextzugriff (PDF)

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain

Diabetes therapy, 2021-05, Vol.12 (5), p.1535-1551

2021

Volltextzugriff (PDF)

Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modeling

BMC proceedings, 2009-12, Vol.3 Suppl 7 (Suppl 7), p.S94-S94, Article S94

2009

Volltextzugriff (PDF)

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study

Advances in therapy, 2021-07, Vol.38 (7), p.3857-3871

2021

Volltextzugriff (PDF)

INTERMEDIATE CHANGES IN COGNITION PREDICT LONG TERM OUTCOMES IN MILD ALZHEIMER’S DISEASE DEMENTIA

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P736-P736

2017

Volltextzugriff (PDF)

P2‐279: COGNITIVE AND FUNCTIONAL DECLINE DURING USUAL CARE OF PATIENTS WITH MILD ALZHEIMER’S DISEASE DEMENTIA WITH AND WITHOUT DIABETES

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_15), p.P737-P737

2016

Volltextzugriff (PDF)

Prognostic Value of Chromogranin A and Neuron-Specific Enolase in Patients with Advanced Pancreatic Neuroendocrine Tumors (pNET): Phase III RADIANT-3 Study Results: 2011 ACG Presidential Poster: 143

The American journal of gastroenterology, 2011-10, Vol.106, p.S58

2011

Volltextzugriff (PDF)

COGNITIVE AND FUNCTIONAL DECLINE DURING USUAL CARE OF PATIENTS WITH MILD ALZHEIMER’S DISEASE DEMENTIA WITH AND WITHOUT DIABETES

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P737-P737

2016

Volltextzugriff (PDF)

P2‐284: Burden in caregivers of Alzheimer's disease patients with and without diabetes

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_13), p.P600-P600

2015

Volltextzugriff (PDF)

Impact of Delayed Arterial Cord Blood Sampling for Lactate Assay

Neonatology (Basel, Switzerland), 2009-03, Vol.95 (3), p.224-229

2009

Volltextzugriff (PDF)

The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12months

Diabetes, obesity & metabolism, 2022-12, Vol.24 (12), p.2373-2382

2022

Volltextzugriff (PDF)

Burden in caregivers of Alzheimer’s disease patients with and without diabetes

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P600-P600

2015

Volltextzugriff (PDF)

Effect of everolimus on angiogenic biomarkers in patients with tuberous sclerosis complex (TSC): Results from EXIST-1 and EXIST-2

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10619-10619

2012

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients ( TROPHIES ): Final patient‐reported outcomes at 24 months

The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes ( TROPHIES ): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data

738-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Patient-Reported Outcomes

746-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Primary Endpoint Analysis

726-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Clinical Characteristics and Treatment Pattern Analyses

672-P: The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Twelve-Month Data Analysis

The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study

Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis

Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain

Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modeling

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study

INTERMEDIATE CHANGES IN COGNITION PREDICT LONG TERM OUTCOMES IN MILD ALZHEIMER’S DISEASE DEMENTIA

P2‐279: COGNITIVE AND FUNCTIONAL DECLINE DURING USUAL CARE OF PATIENTS WITH MILD ALZHEIMER’S DISEASE DEMENTIA WITH AND WITHOUT DIABETES

Prognostic Value of Chromogranin A and Neuron-Specific Enolase in Patients with Advanced Pancreatic Neuroendocrine Tumors (pNET): Phase III RADIANT-3 Study Results: 2011 ACG Presidential Poster: 143

COGNITIVE AND FUNCTIONAL DECLINE DURING USUAL CARE OF PATIENTS WITH MILD ALZHEIMER’S DISEASE DEMENTIA WITH AND WITHOUT DIABETES

P2‐284: Burden in caregivers of Alzheimer's disease patients with and without diabetes

Impact of Delayed Arterial Cord Blood Sampling for Lactate Assay

The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12months

Burden in caregivers of Alzheimer’s disease patients with and without diabetes

Effect of everolimus on angiogenic biomarkers in patients with tuberous sclerosis complex (TSC): Results from EXIST-1 and EXIST-2

Aktive Filter

Suchergebnisse filtern